Industry’s role in policymaking: Vested interest or critical partner?
Date
Address
Section
Event Location
Event Description
Industry’s role in policymaking: Vested interest or critical partner?
Wednesday, October 19, 2016 from 6:30 PM - 8:30 PM
We have the pleasure of inviting you to a debate on Industry’s role in policymaking. The event will see the launch of our report examining the Role of Industry in EU policymaking.
The notion that some industry sectors have an excessive influence over policymaking has gained currency in recent years and there is increasingly anti-corporate sentiments in some quarters. There is now a major focus on transparency in Brussels and the European Commission will be proposing a new inter-institutional agreement on the Transparency Register. This raises important questions for industry and other stakeholders involved in EU policymaking.
- Is industry a vested interest?
- What are the benefits or costs of industry participation?
- Can there be too much transparency and what effects can this have?
- What trends are we likely to see emerge when it comes to industry involvement and industry access to policymaking?
Join us as we share the outcomes of the research and look at these questions and more. We will announce the panelists at the beginning of October. The discussion will be followed by a cocktail reception.
We hope to see you there.
Related Events
Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.
Monday 5 November 2012 (day 1)
15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Pages
Events of the week
Jobs
EURACTIV News
- Hungarian presidency secures full Schengen membership for Bulgaria, Romania
- Hungary seeks organ transplant increase, boost to organ recipient life quality and reduced stigma
- Orbán to host Netanyahu in Hungary as EU divided over ICC decision
- EU budget 2025 – an investment in Europeans [Promoted content]
- Barnier: Franco-German tandem should enter ‘ménage à trois’ with Italy